产品名称: | 重组人转化生长因子β-1 |
---|---|
产品又名: | TGFB1细胞因子, TGFB细胞因子 |
英文名称: | Transforming Growth Factor Beta-1; TGF-Beta-1; Latency-Associated Peptide; LAP; TGFB1; TGFB |
产品说明: | 重组人转化生长因子β1由我们的哺乳动物表达系统产生,并表达了编码Leu30-Arg278(Cys33Ser)的靶基因。 |
背景说明: | 转化生长因子β-1(TGF-β-1)是一种分泌型蛋白,属于转化生长因子-β家族.转化生长因子β-1在骨、关节软骨和软骨细胞中大量表达,在骨关节炎(OA)中表达增加。转化生长因子β-1具有多种细胞功能,包括对细胞生长、细胞增殖、细胞分化和凋亡的调控。前体被切割成潜伏期相关肽(LAP)和成熟的转化生长因子β-1肽,分泌后LAP和TGF-β1的二硫键连接的同源二聚体仍非共价结合,形成小的潜在的TGF-β1复合物。纯化的LAP也能与高亲和力的活性TGF-β结合,并能中和TGF-β的活性。LAP与三种潜在TGF-β结合蛋白(LTBPs)中的一种共价连接,形成一个巨大的潜在复合物,可能与细胞外基质相互作用。潜伏期引起的TGF-β激活在时间和空间上都受到多种途径的控制,包括纤溶酶和MMP 9等蛋白酶的作用,以及(或)凝血酶敏感素1或某些整合素的作用。虽然TGF-β的不同亚型自然与它们各自不同的圈相关联,但TGF-β1 LAP能够与所有其他人和大多数其他物种的TGF-β异构体结合,并使其失活。LAP中的突变与Camurati-Engelmann病有关,Camurati-Engelmann病是一种罕见的硬化性骨发育不良,其特征是活性TGF-β1的不适当存在。 |
级别: | AR |
品牌: | ELITE-MEDIA |
产品目录号: | P01137 |
产品规格: | 10ug、50ug |
产品外观: | 乳白色均一粉末。 |
制剂: | 冻干从0.2μm过滤的PBS溶液中,pH7.4。 |
保存条件: |
冻干蛋白应保存在<-20°C,室温下保存3周。
重组蛋白溶液可在4-7℃保存2~7d。
重组样品在<-20℃温度下稳定3个月。
|
质量控制: |
纯度:通过减少SDS-PAGE而确定的95%以上。
内毒素:LAL法测定小于0.1ng/g(1 Eu/?g)。
|
注意事项: | 避免呼入和皮肤接触。 |
文献引用: |
Transforming Growth Factor β-1 (TGFβ-1) is a secreted protein which belongs to the TGF-β family. TGFβ-1 is abundantly expressed in bone, articular cartilage and chondrocytes and is increased in osteoarthritis (OA). TGFβ-1 performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation and apoptosis. The precursor is cleaved into a latency-associated peptide (LAP) and a mature TGFβ-1 peptide.Disulfide-linked homodimers of LAP and TGF-beta 1 remain non-covalently associated after secretion, forming the small latent TGF-beta 1 complex. Purified LAP is also capable of associating with active TGF-beta with high affinity, and can neutralize TGF-beta activity. Covalent linkage of LAP to one of three latent TGF-beta binding proteins (LTBPs) creates a large latent complex that may interact with the extracellular matrix. TGF-beta activation from latency is controlled both spatially and temporally, by multiple pathways that include actions of proteases such as plasmin and MMP9, and/or by thrombospondin 1 or selected integrins. Although different isoforms of TGF-beta are naturally associated with their own distinct LAPs, the TGF-beta 1 LAP is capable of complexing with, and inactivating, all other human TGF-beta isoforms and those of most other species. Mutations within the LAP are associated with Camurati-Engelmann disease, a rare sclerosing bone dysplasia characterized by inappropriate presence of active TGF-beta 1.
|
买家导航
TGFB细胞因子产品基本信息
TGFB细胞因子产品说明书pdf版和相关资料下载
TGFB细胞因子产品应用举例
- 上一篇:TNFRSF1B细胞因子
- 下一篇:TNFRSF13C细胞因子